Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prospective Validation of an Ex Vivo, Patient-Derived 3D Spheroid Model for Response Predictions in Newly Diagnosed Ovarian Cancer.
Journal: Scientific reports
Published: February 03, 2019
Differential Expression of KRAS and SIRT1 in Ovarian Cancers with and Without Endometriosis.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: January 17, 2019
Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study.
Journal: Gynecologic oncology
Published: July 07, 2015
A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer.
Journal: Gynecologic oncology
Published: May 09, 2013
New-onset congestive heart failure with gemcitabine in ovarian and other solid cancers.
Journal: American journal of clinical oncology
Published: January 30, 2013
Continuing routine cardiac surveillance in long-term use of pegylated liposomal doxorubicin: is it necessary?
Journal: Gynecologic oncology
Published: January 25, 2013
Simultaneous occurrence of well differentiated papillary mesothelioma and endometrioid ovarian cancer: A case report.
Journal: Gynecologic oncology case reports
Published: December 06, 2012
A phase II evaluation of docetaxel and carboplatin followed by tumor volume directed pelvic plus or minus paraaortic irradiation for stage III endometrial cancer.
Journal: Gynecologic oncology
Published: December 22, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026